BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33073679)

  • 1. mTOR Inhibition Ablates Cisplatin-Resistant Salivary Gland Cancer Stem Cells.
    Nakano T; Warner KA; Oklejas AE; Zhang Z; Rodriguez-Ramirez C; Shuman AG; Nör JE
    J Dent Res; 2021 Apr; 100(4):377-386. PubMed ID: 33073679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival of salivary gland cancer stem cells requires mTOR signaling.
    Andrade NP; Warner KA; Zhang Z; Pearson AT; Mantesso A; Guimaraēs DM; Altemani A; Mariano FV; Nunes FD; Nör JE
    Cell Death Dis; 2021 Jan; 12(1):108. PubMed ID: 33479203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic inhibition of Bmi-1 ablates chemoresistant cancer stem cells in adenoid cystic carcinoma.
    Sahara S; Warner KA; Herzog AE; Zhang Z; Nör JE
    Oral Oncol; 2023 Jul; 142():106437. PubMed ID: 37267716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 Inhibits Bmi-1-driven Self-Renewal and Defines Salivary Gland Cancer Stemness.
    Rodriguez-Ramirez C; Zhang Z; Warner KA; Herzog AE; Mantesso A; Zhang Z; Yoon E; Wang S; Wicha MS; Nör JE
    Clin Cancer Res; 2022 Nov; 28(21):4757-4770. PubMed ID: 36048559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitizing mucoepidermoid carcinomas to chemotherapy by targeted disruption of cancer stem cells.
    Guimarães DM; Almeida LO; Martins MD; Warner KA; Silva AR; Vargas PA; Nunes FD; Squarize CH; Nör JE; Castilho RM
    Oncotarget; 2016 Jul; 7(27):42447-42460. PubMed ID: 27285758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumor effect of inhibition of IL-6 signaling in mucoepidermoid carcinoma.
    Mochizuki D; Adams A; Warner KA; Zhang Z; Pearson AT; Misawa K; McLean SA; Wolf GT; Nör JE
    Oncotarget; 2015 Sep; 6(26):22822-35. PubMed ID: 26287605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALDH/CD44 identifies uniquely tumorigenic cancer stem cells in salivary gland mucoepidermoid carcinomas.
    Adams A; Warner K; Pearson AT; Zhang Z; Kim HS; Mochizuki D; Basura G; Helman J; Mantesso A; Castilho RM; Wicha MS; Nör JE
    Oncotarget; 2015 Sep; 6(29):26633-50. PubMed ID: 26449187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer.
    Nör C; Zhang Z; Warner KA; Bernardi L; Visioli F; Helman JI; Roesler R; Nör JE
    Neoplasia; 2014 Feb; 16(2):137-46. PubMed ID: 24709421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary Gland Cancer Patient-Derived Xenografts Enable Characterization of Cancer Stem Cells and New Gene Events Associated with Tumor Progression.
    Keysar SB; Eagles JR; Miller B; Jackson BC; Chowdhury FN; Reisinger J; Chimed TS; Le PN; Morton JJ; Somerset HL; Varella-Garcia M; Tan AC; Song JI; Bowles DW; Reyland ME; Jimeno A
    Clin Cancer Res; 2018 Jun; 24(12):2935-2943. PubMed ID: 29555661
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.
    Keysar SB; Le PN; Miller B; Jackson BC; Eagles JR; Nieto C; Kim J; Tang B; Glogowska MJ; Morton JJ; Padilla-Just N; Gomez K; Warnock E; Reisinger J; Arcaroli JJ; Messersmith WA; Wakefield LM; Gao D; Tan AC; Serracino H; Vasiliou V; Roop DR; Wang XJ; Jimeno A
    J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27634934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Significance of Cancer Stem Cell Markers in Patients With Salivary Gland Carcinomas.
    Sadeghi H; Saffar H; Taheri P; Yazdani F; Etebarian A
    Appl Immunohistochem Mol Morphol; 2022 Apr; 30(4):284-290. PubMed ID: 35001035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression.
    Deng J; Bai X; Feng X; Ni J; Beretov J; Graham P; Li Y
    BMC Cancer; 2019 Jun; 19(1):618. PubMed ID: 31234823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-Blocking of PI3K and mTOR Improves Chemotherapeutic Effects on SW620 Human Colorectal Cancer Stem Cells by Inducing Differentiation.
    Kim MJ; Koo JE; Han GY; Kim B; Lee YS; Ahn C; Kim CW
    J Korean Med Sci; 2016 Mar; 31(3):360-70. PubMed ID: 26955235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between high expression of phosphorylated Akt and mammalian target of rapamycin and improved survival in salivary gland adenoid cystic carcinoma.
    Ouyang DQ; Liang LZ; Ke ZF; Zheng GS; Weng DS; Yang WF; Su YX; Liao GQ
    Head Neck; 2017 Jun; 39(6):1145-1154. PubMed ID: 28230926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Embryonic stem cells markers Oct4 and Nanog correlate with perineural invasion in human salivary gland mucoepidermoid carcinoma.
    Destro Rodrigues MF; Sedassari BT; Esteves CM; de Andrade NP; Altemani A; de Sousa SC; Nunes FD
    J Oral Pathol Med; 2017 Feb; 46(2):112-120. PubMed ID: 27131799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic efficacy of combined EGFR and HDAC inhibitors overcomes tolerance to EGFR monotherapy in salivary mucoepidermoid carcinoma.
    Parag-Sharma K; Tasoulas J; Musicant AM; do Nascimento-Filho CHV; Zhu Z; Twomey C; Liu P; Castilho RM; Amelio AL
    Oral Oncol; 2021 Apr; 115():105166. PubMed ID: 33581505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The IL-6R and Bmi-1 axis controls self-renewal and chemoresistance of head and neck cancer stem cells.
    Herzog AE; Warner KA; Zhang Z; Bellile E; Bhagat MA; Castilho RM; Wolf GT; Polverini PJ; Pearson AT; Nör JE
    Cell Death Dis; 2021 Oct; 12(11):988. PubMed ID: 34689150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Notch and EGFR signaling in human mucoepidermoid carcinoma.
    Ni W; Chen Z; Zhou X; Yang R; Yu M; Lu J; Kaye FJ; Wu L
    Signal Transduct Target Ther; 2021 Jan; 6(1):27. PubMed ID: 33473104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting cancer stem cells in glioblastoma multiforme using mTOR inhibitors and the differentiating agent all-trans retinoic acid.
    Friedman MD; Jeevan DS; Tobias M; Murali R; Jhanwar-Uniyal M
    Oncol Rep; 2013 Oct; 30(4):1645-50. PubMed ID: 23877261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGFR signaling regulates resistance of head and neck cancer stem cells to cisplatin.
    McDermott SC; Rodriguez-Ramirez C; McDermott SP; Wicha MS; Nör JE
    Oncotarget; 2018 May; 9(38):25148-25165. PubMed ID: 29861860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.